Cetuximab sarotalocan, CAS 2166339-33-7

Product Description: Cetuximab sarotalocan (RM-1929) is an IRdye700DX (near-infrared photosensitizing dye) conjugate of Cetuximab (anti-EGFR monoclonal antibody). Cetuximab sarotalocan can be used for head and neck cancers research[1][2].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Go Omura, et al. Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma. Auris Nasus Larynx. 2022 Jun 29;S0385-8146(22)00167-5. /[2]Isaku Okamoto, et al. Quality-of-Life Evaluation of Patients with Unresectable Locally Advanced or Locally Recurrent Head and Neck Carcinoma Treated with Head and Neck Photoimmunotherapy. Cancers (Basel). 2022 Sep 11;14(18):4413.

CAS Number: 2166339-33-7

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: EGFR

• SKU: MEXHY-P99500-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99500-1
• Package Unit: 1 mg
• Quantity Unit: STK